Search results
Results from the WOW.Com Content Network
Targeted temperature management (TTM), previously known as therapeutic hypothermia or protective hypothermia, is an active treatment that tries to achieve and maintain a specific body temperature in a person for a specific duration of time in an effort to improve health outcomes during recovery after a period of stopped blood flow to the brain. [1]
Hypothermia is the cause of at least 1,500 deaths a year in the United States. [2] It is more common in older people and males. [5] One of the lowest documented body temperatures from which someone with accidental hypothermia has survived is 12.7 °C (54.9 °F) in a 2-year-old boy from Poland named Adam. [6]
Since 2000, IDSA has recommended against long-term antibiotic treatment for Lyme disease, finding that it is ineffective and potentially harmful. [18] [19] The American Academy of Neurology, Centers for Disease Control and Prevention, National Institutes of Health, and medical groups around the world similarly recommend against such treatment.
Exposure to cold temperatures [6] Risk factors: Military occupation, recreational winter activities, homelessness, inadequate or wet clothing, substance abuse, diabetes, peripheral vascular disease [6] [7] Diagnostic method: Based on symptoms [1] [6] Differential diagnosis: Hypothermia, Raynaud's phenomenon, chilblains (pernio), cold urticaria ...
EPR uses hypothermia, drugs, and fluids to "buy time" for resuscitative surgery. If successful, EPR may someday be deployed in the field so that paramedics can suspend and preserve patients for transport. EPR is similar to deep hypothermic circulatory arrest (DHCA) in that hypothermia is induced. However, the purposes and procedures of EPR ...
Because of the Arctic Sun's noninvasive nature, treatment can be delivered without the host of adverse events associated with invasive procedures such as cooling catheters. [6] The Arctic Sun has adhesive gel pads which stick to a patient's body, and cover only a portion of a patient's body to leave most of the body free for augmenting medical ...
While moderate hypothermia may be satisfactory for short surgeries, deep hypothermia (20 °C to 25 °C) affords protection for times of 30 to 40 minutes at the bottom of this temperature range. Profound hypothermia (< 14 °C) usually isn't used clinically. It is a subject of research in animals and human clinical trials.
At present data relate only to full term infants, and all human studies of hypothermia treatment have so far been restricted to infants >36 weeks out of an expected 40 weeks gestation. There are both more potential side effects on the developing premature with lung disease , and there is more evident protection by hypothermia when a greater ...